WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Developed economy GNI / capita (US$): 20'5801 Infant (under 12 months) mortality rate: 32
GDP / capita (US$): 25'3051 Child (under 5 years) mortality rate: 32

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 10'604  10'598  10'590  10'581  10'570  10'306  9'899  9'765 
Births 94  96  98  100  102  114  114  160 
Surviving infants 94  95  97  99  102  113  113  156 
Pop. less than 5 years 486  497  513  524  536  540  565  813 
Pop. less than 15 years 1'579  1'590  1'604  1'613  1'624  1'667  2'035  2'518 
Female 15-49 years 2'496  2'517  2'536  2'555  2'571  2'623  2'460  2'357 

Number of reported case

(Click for retrospective incidence data for Portugal)
Diphtheria 90 
Japanese encephalitis
Measles 23  45  407 
Mumps 158  134  140  154  140  6'493 
Pertussis 224  32  14  68  69  22  101  71 
Polio*
Rubella 58 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total) 15  34  73 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Portugal)
Vaccine year result method % card seen                                                
BCG 1997  87       99  97  96  98  98  82  88 
DTP1          97  99*  99 
DTP3 1997  98       98  97  98  96  97  96  89  73 
HepB_BD          97  97  96  95  95  64 
HepB3          98  97  97  96  97  58 
Hib3          98  97  97  96  97  86 
JapEnc         
MCV 1997  99       97  97  96  95  97  87  85  54 
MCV2          96  96  95  95  95  49 
PCV1         
PCV3         
Pol3 1997  97       98  97  97  96  97  96  89  18 
Rota1         
Rota_last         
Rubella1          97  97  96  95  97 
TT2plus         
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Portugal)
BCG 99  98  96  98  98  82  88 
DTP1 99  99  99  97  99  99  96  90 
DTP3 98  98  98  96  97  96  89  73 
HepB3 98  98  97  96  97  58 
Hib3 98  98  97  96  97  86 
MCV 97  97  96  95  97  87  85  54 
PCV3
Pol3 98  98  97  96  97  96  89  18 
Rota_last

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90% 100
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTaPHib 18 months; Yes
DTaPHibIPV 2, 4, 6 months; Yes
DTaPIPV 5-6 years; Yes
HPV 13 years, +2, +6 months; Yes
HepB birth; 2, 6 months; Yes
MMR 12 months; 5-6 years; Yes
MenC_conj 12 months; Yes
Td 10-13 years; Yes every 10 years

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR Yes  Yes  Yes  Yes  No  Yes  No 
What years does the MYP cover? number continuous  continuous  continuous  continuous      NA 
Nº of districts with microplans that include activities to raise immunization coverage number     20  20 

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR Yes  Yes  Yes         

System performance

Total number of districts in country number 20  20  20  20 
Nº districts with DTP3 coverage >=80% number   20  20  20 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  100    100  100  100 
Nº districts with measles (MCV1) coverage >=95% number   20     
% of districts with MCV1 coverage >=95% From 0 to 100% 71  86  71    100     

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes         

Finance

Percentage of routine vaccines funded by Government From 0 to 100% 100  100  100         

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.